Why the study?
Does continuous ST-segment monitoring predict 30-day death or nonfatal myocardial infarction in patients with non-ST-segment elevation acute coronary syndromes?
Population
183 patients admitted due to chest pain at rest suggestive of a non-ST-segment elevation acute coronary…
Comparison
Continuous ST-segment monitoring for 24 hours… vs Patients without ST episodes
Design
Cohort
Follow-up
30 days
Authors
Loading...
ST episodes may aid early risk stratification in NSTE-ACS; leaves open whether monitoring improves outcomes in prospective trials.
Does continuous ST-segment monitoring predict 30-day death or nonfatal myocardial infarction in patients with non-ST-segment elevation acute coronary syndromes?
Continuous ST-segment monitoring, in combination with troponin I levels, provides early prognostic information and risk stratification in patients with non-ST-segment elevation acute coronary syndromes.
Aguíar et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: